The Exchange has received the disclosure under Regulation 29(1) / 2(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tejash Hathi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma promoter Mr. Tejash Maheshchandra Hathi acquired 10,000 equity shares (0.15%) on May 11, 2026, increasing his total holding from 11.30% to 11.44% of the company's equity capital. The total equity capital of the company is 68,60,000 shares of Rs. 10 each. The acquirer confirmed he belongs to the Promoter/Promoter group. The filing is submitted under Regulation 29(1) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011, and the shares are listed on BSE Limited (SME).
This is a minor incremental purchase by an existing promoter, representing a small positive signal of promoter confidence in the company. The acquisition is small (0.15%) and unlikely to have immediate impact on the stock price.